Acceptability of a Hypothetical Zika Vaccine among Women from Colombia and Spain Exposed to ZIKV: A Qualitative Study
Zika virus (ZIKV) can cause pregnancy loss and congenital Zika syndrome, among other poor health outcomes. The ZIKV epidemic in 2015–2017 disproportionately affected pregnant women in poor-resource settings. We aimed to understand perceptions and attitudes towards a hypothetical ZIKV vaccine, women’...
- Autores:
-
Marbán Castro, Elena
Villén Gonzalvo, Ana
Enguita Fernández, Cristina
Romero Acosta, Kelly Carolina
Marín Cos, Anna
Arrieta Bernate, Germán Javier
Mattar Velilla, Ameth Salim
Menéndez, Clara
Maixenchs, María
Bardají, Azucena
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Corporación Universitaria del Caribe - CECAR
- Repositorio:
- Repositorio Digital CECAR
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.cecar.edu.co:cecar/10805
- Acceso en línea:
- https://repositorio.cecar.edu.co/handle/cecar/10805
- Palabra clave:
- Zika
Vaccine
Acceptability
Pregnancy
Qualitative
Grounded theory
- Rights
- openAccess
- License
- Derechos reservados - Corporación Universitaria de Caribe - CECAR
| Summary: | Zika virus (ZIKV) can cause pregnancy loss and congenital Zika syndrome, among other poor health outcomes. The ZIKV epidemic in 2015–2017 disproportionately affected pregnant women in poor-resource settings. We aimed to understand perceptions and attitudes towards a hypothetical ZIKV vaccine, women’s willingness to be vaccinated, and potential barriers and facilitators for vaccine acceptance in 1) migrant women living in Spain who travelled to their countries of origin and were diagnosed with ZIKV infection during pregnancy, and their healthcare providers, and 2) women living in Colombia who delivered a child with microcephaly. An exploratory qualitative study based on phenomenology and grounded theory was conducted. Data were collected through in-depth, paired and semi-structured interviews. Overall, women from both sites were willing to receive a hypothetical ZIKV vaccine. However, some expressed concerns of being vaccinated during pregnancy, yet they would accept it if the vaccine was recommended by a healthcare professional they trust. Main fears towards vaccination were related to vaccine safety and potential adverse effects on child’s health. Women reported feeling hesitant to participate in a ZIKV vaccine trial. These results may contribute to guiding the effective delivery of future ZIKV vaccines among populations most at risk and particularly vulnerable. |
|---|